Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48067 - knee wedge - composed of tial6v4 with silver coating on outer contour. connect to the distal part of the condyles of the mutars genux mk femur cemented with mk spacer screws. can only be used with a genux mk femur cemented of the corresponding size. the surfaces of the spacers are sandblasted & 0.7 mm deep cement pockets are provided to augment bone cement fixation. bore holes (6.5 mm diameter) are provided for the 6.5 mm mk spacer attachment screws used to secure the spacers to the femoral component. a component of the mutars system intended for used for bridging bone defects on the medial and lateral aspects of the distal femur. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

mk pharmaceuticals pty ltd - bifidobacterium lactis,colecalciferol,inulin,lactobacillus brevis,lactobacillus gasseri,lactobacillus plantarum,lactobacillus rhamnosus,lactobacillus salivarius ssp salivarius,zinc oxide -

Australia - English - Department of Health (Therapeutic Goods Administration)

mk pharmaceuticals pty ltd - bifidobacterium lactis,lactobacillus brevis,lactobacillus gasseri,lactobacillus plantarum,lactobacillus salivarius ssp salivarius,lepidium meyenii -

Australia - English - Department of Health (Therapeutic Goods Administration)

mk pharmaceuticals pty ltd - bifidobacterium lactis,lactobacillus acidophilus,lactobacillus brevis,lactobacillus gasseri,lactobacillus plantarum,lactobacillus rhamnosus,lactobacillus salivarius ssp salivarius,vaccinium macrocarpon -

Australia - English - Department of Health (Therapeutic Goods Administration)

mk pharmaceuticals pty ltd - bifidobacterium lactis,colecalciferol,inulin,lactobacillus brevis,lactobacillus gasseri,lactobacillus plantarum,lactobacillus rhamnosus,lactobacillus salivarius ssp salivarius,zinc oxide -

Australia - English - Department of Health (Therapeutic Goods Administration)

mk pharmaceuticals pty ltd - bifidobacterium lactis,fructooligosaccharides,inulin,lactobacillus rhamnosus -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan succinate, quantity: 16.8 mg/ml (equivalent: sumatriptan, qty 12 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride - sumatriptan (imigran) tablets, injection and nasal spray are indicated for the acute relief of migraine attacks with or without aura. sumatriptan (imigran) injection is also indicated for the acute treatment of cluster headaches. there is no information available on the use of imigran injection in the treatment of basilar or hemiplegic migraine.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan succinate, quantity: 16.8 mg/ml (equivalent: sumatriptan, qty 12 mg/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections - sumatriptan (imigran) tablets, injection and nasal spray are indicated for the acute relief of migraine attacks with or without aura. sumatriptan (imigran) injection is also indicated for the acute treatment of cluster headaches. there is no information available on the use of imigran injection in the treatment of basilar or hemiplegic migraine.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48067 - knee wedge - composed of tial6v4 with silver coating on outer contour. bilateral configuration & connected below a mutars genux mk tibia cemented component by screws. can only be combined with a tibial component of the corresponding size. symmetrical & have slots for the fins of the tibial component. a flattening at the front of the spacer is provided for preserving the tibial tuberosity & holes for the fixation of the soft tissue. to be used with bone cement, the surfaces have a sandblasted finish. a component of the mutars system intended for bridging bone defects in the proximal tibia. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48067 - knee wedge - composed of tial6v4 with silver coating on outer contour. can only be used with cemented genux mk tibial component of the corresponding size. slots included for the fins of the tibial component & flattening at the front of the spacer is provided for preserving the tibial tuberosity. holes are provided for the fixation of soft tissues. the spacers have 6.5 mm diameter bore holes for screw attachment to the distal aspect of the cemented mutars genux mk tibial component. for use with bone cement. a component of the mutars system intended for bridging bone defects in the area of the proximal tibia. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.